T50.B13
Poisoning by smallpox vaccines, assault
Clinical Classification Guidelines
Medical Intelligence & Overview
Poisoning by smallpox vaccines, assault (ICD-10 code T50.B13), refers to adverse health effects resulting from deliberate or accidental exposure to smallpox vaccines. This condition can emerge when the vaccine is administered improperly, under unapproved circumstances, or through malicious intent. While smallpox vaccination has played a vital role in controlling the disease historically, improper administration or malicious acts leading to poisoning can cause significant health issues. Recognizing and understanding the causes, symptoms, and treatment options is essential for healthcare management and patient safety.
Causes & Symptoms
Clinical Causes: Deliberate ingestion or exposure to smallpox vaccine with harmful intent (assault) Administration of an incorrect vaccine formulation or dosage Contamination of the vaccine with toxic substances or pathogens Improper handling or storage of the vaccine leading to degradation or contamination Accidental exposure during manufacturing or clinical use
Key Symptoms: Local skin reactions such as redness, swelling, pain, or blistering at the injection site Fever and chills Nausea and vomiting Respiratory symptoms like cough or difficulty breathing if systemic poisoning occurs Rashes or skin lesions beyond the injection area Signs of systemic toxicity, including malaise, weakness, or dizziness Potential for allergic reactions, which may include swelling, itching, or anaphylaxis in severe cases
Diagnostic & Treatment
Diagnosis Path: Detailed patient history focusing on recent vaccination, exposure events, or assault circumstances Physical examination to identify local and systemic reactions Laboratory tests to detect vaccine components or toxins in blood, tissue, or other samples Monitoring for additional signs of infection or toxicity Imaging or skin biopsies if necessary to assess tissue damage
Treatment Protocols: Immediate removal of contaminated or residual vaccine material if accessible Supportive treatments such as intravenous fluids and medications to control symptoms Administration of antipyretics for fever Antihistamines or corticosteroids for allergic reactions Use of antiviral or detoxifying agents if indicated and available Treatment of any secondary infections or complications Psychological support or counseling if assault was malicious
Clinical Advice & FAQs
Billing Guidance
Is T50.B13 a billable ICD-10 code?
Yes, T50.B13 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T50.B13?
Clinical documentation must specify the nature of Poisoning by smallpox vaccines, assault and any associated comorbidities for accurate reporting.
Cite this Clinical Reference